# Novel direct effect of CCR2 receptor on follicle activation process

**Authors:** Yamila Gamaleri, Delfina Sol Ferman, Alison Ting, Eduardo Raúl Dascal, Alejandro Lomniczi, Juan Pablo Jaworski, Marina Cinthia Peluffo

PMC · DOI: 10.3389/fendo.2025.1613270 · Frontiers in Endocrinology · 2025-08-01

## TL;DR

This study shows that the CCR2 receptor and its ligand CCL2 play a direct role in activating ovarian follicles in cats, influencing fertility-related processes.

## Contribution

The study demonstrates a novel direct effect of the CCR2 receptor on follicle activation in the ovarian cortex.

## Key findings

- CCR2 stimulation increased mRNA expression of KIT, FOXO3, and AKT in ovarian cortex fragments.
- CCL2 increased transitional follicles and oocyte size while decreasing primordial follicles.
- CCR2 signaling enhanced cell proliferation markers and AKTp staining in follicles.

## Abstract

The regulation of primordial follicle activation is crucial for maintaining ovarian function, the duration of the reproductive phase, and fertility in women; therefore, we propose as our general objective to determine the physiological role of the chemokine receptor CCR2 within the follicular activation process.

Ovarian cortex fragments from adult domestic cats (Felis catus) were cultured under different experimental groups: control (media alone), CCR2 antagonist (1µM), and recombinant chemokine CC-motif ligand 2 (CCL2) at two concentrations (10 ng/ml and 100 ng/ml) for 4 h or 48 h. At the end of the culture, the fragments were collected for RNA extraction, cDNA synthesis, and quantitative real-time PCR (4 h) or fixed and processed for paraffin embedding (48 h) for hematoxylin and eosin staining or immunohistochemistry for Ki67, bromodeoxyuridine (BrdU) and AKTp.

Stimulation of CCR2 significantly increased the normalized mRNA expression of KIT, FOXO3 (10 ng/ml), and AKT (100 ng/ml) compared to the control (p<0,05). Moreover, there was a significant increase in the percentage of transitional follicles (and a decrease in primordial follicles), together with an increase in oocyte diameter compared with the control and the antagonist groups (p<0.05). Also, in the presence of CCL2, a higher proportion of transitional and primary follicles immunolabeled for BrdU and Ki67 (p<0.05), as well as intense AKTp staining in the nucleus and cytoplasm of oocyte and granulosa cells of primordial, transitional and primary follicles, were observed. On the contrary, a lower proportion of BrdU and Ki67-positive follicles were observed in the antagonist group (p < 0,05).

Our results show a direct effect of the chemokine CCL2 and a role of the CCR2/CCL2 system on the ovarian cortex, suggesting that the CCR2 receptor signaling in the ovarian cortex may regulate events critical for promoting the stimulation of the transition from primordial to primary follicles.

## Linked entities

- **Genes:** CCR2 (C-C motif chemokine receptor 2) [NCBI Gene 729230], CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347], KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815], FOXO3 (forkhead box O3) [NCBI Gene 2309], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207]
- **Proteins:** CCR2 (C-C motif chemokine receptor 2), CCL2 (C-C motif chemokine ligand 2), KIT (KIT proto-oncogene, receptor tyrosine kinase), FOXO3 (forkhead box O3), AKT1 (AKT serine/threonine kinase 1), Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Species:** Felis catus (taxon 9685)

## Full-text entities

- **Genes:** FOXO3 [NCBI Gene 101081548], CCR2 [NCBI Gene 100049057], KIT [NCBI Gene 493766]
- **Chemicals:** 1microM (-), paraffin (MESH:D010232)
- **Species:** Felis catus (cat, species) [taxon 9685], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12353731/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12353731/full.md

## References

69 references — full list in the complete paper: https://tomesphere.com/paper/PMC12353731/full.md

---
Source: https://tomesphere.com/paper/PMC12353731